What you should know:
1. Acino will acquire 30 select prescription pharmaceutical and OTC products. The assets are all located in the Near East, Middle East and Africa markets.
2. Takeda is in the process of selling non-core assets to combat the debt it took on during its acquisition of Shire. Takeda became one of the most indebted drugmakers in the world after it acquired Shire.
3. The companies expect the transactions will close in the fourth quarter of 2019.
More articles on surgery centers:
10 states with the highest year-over-year growth in ASCs
6 hospitals, health systems opening or planning ASCs
ASC payer mix, procedure costs & out-of-pocket expenses — 5 statistics
